Investor Relationship

AmProtein is a privately held biotechnology powerhouse company.

AmProtein Corporation is divided into 6 functional areas. Five of the six divisions are based on AmProtein's breakthrough discoveries in gene expression and oxygen transfer. The patents and ideas have expanded into a full product line that spans several fields of the biotechnology industry and act as foundations for their respective divisions.

AmProtein's Divisions include:

  • Bioreactors & Medium
    • CURRENT Suspension & Perfusion Bioreactor Systems
    • Supporting Mini-bioreactor Systems
    • Supporting Accessories
  • Expression Systems
    • pMH 3 -5 Vector Series for Mammalian, Fish & Chicken
    • Ongoing Research & Development for Plant Vector
  • Medical Device
    • 'Artificial Lung' DO Generator Heart Bypass Machine for safe long-term culture of whole blood cells & oxygen transfer
  • Vaccine
    • Breakthrough High Density Cell Culture Manufacture Process for Mammals, Fish, and Chicken Vaccine Production Cells
    • Breakthrough High Density Cell Culture Manufacture Process for Human Vaccine Production Cells
  • Therapeutics & Contract Service
    • Dual-Domain Drug Candidates
    • Hyper-G Fusion Technology (replaces Pegylation method)
    • Generics & Modified Generics
  • Marketing
    • Multinational Commercial Database Development by using Chinese educated labor force

AmProtein welcomes investors to invest in the separate branches or in AmProtein Corporation itself. This promotes the low-risk, stable investment AmProtein values.